110 related articles for article (PubMed ID: 8438433)
1. Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection.
Häyry P; Mennander A; Paavonen T; Räisänen A; Ustinov J
Transplant Proc; 1993 Feb; 25(1 Pt 1):603-4. PubMed ID: 8438433
[No Abstract] [Full Text] [Related]
2. Cyclosporine-induced endothelialitis and accelerated arteriosclerosis in chronic allograft rejection.
Mennander A; Paavonen T; Häyry P
Transplant Proc; 1992 Feb; 24(1):341. PubMed ID: 1539306
[No Abstract] [Full Text] [Related]
3. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis.
Mennander A; Tikkanen MJ; Räisänen-Sokolowski A; Paavonen T; Ustinov J; Häyry P
J Heart Lung Transplant; 1993; 12(1 Pt 1):123-31; discussion 131-2. PubMed ID: 8443189
[TBL] [Abstract][Full Text] [Related]
4. Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis.
Häyry P; Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T
Transplant Proc; 1991 Feb; 23(1 Pt 1):611-2. PubMed ID: 1990624
[No Abstract] [Full Text] [Related]
5. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection).
Räisänen-Sokolowski A; Myllärniemi M; Häyry P
Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125
[No Abstract] [Full Text] [Related]
6. Chronic rejection of rat aortic allografts. III. Synthesis of major eicosanoids by vascular wall components and effect of inhibition of the thromboxane cascade.
Mennander A; Tiisala S; Ustinov J; Räisänen A; Paavonen T; Häyry P
Arterioscler Thromb; 1992 Dec; 12(12):1380-6. PubMed ID: 1450170
[TBL] [Abstract][Full Text] [Related]
7. Effects of immunosuppressive therapy on the rat aortic allograft model.
Steele DM; Hullett DA; Bechstein WO; Kowalski J; Smith LS; Kennedy E; Allison AC; Sollinger HW
Transplant Proc; 1993 Feb; 25(1 Pt 1):754-5. PubMed ID: 8438469
[No Abstract] [Full Text] [Related]
8. Clinical and experimental chronic allograft rejection.
Häyry P; Isoniemi H; Yilmaz S; Mennander A; Lemström K; Räisänen A; Koskinen P; Ustinov J; Lautenschalger I; Taskinen E
Transplant Proc; 1994 Jun; 26(3):1702-3. PubMed ID: 8030092
[No Abstract] [Full Text] [Related]
9. Mechanism of action of 15-deoxyspergualin in allograft arteriosclerosis in rat aortic transplants.
Räisänen-Sokolowski A; Aho P; Tufveson G; Häyry P
Transplant Proc; 1994 Dec; 26(6):3224. PubMed ID: 7998124
[No Abstract] [Full Text] [Related]
10. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin.
Räisänen-Sokolowski A; Yilmaz S; Tufveson G; Häyry P
Transplantation; 1994 Jun; 57(12):1772-7. PubMed ID: 8016883
[TBL] [Abstract][Full Text] [Related]
11. Chronic rejection in rat aortic allograft: mechanism of angiopeptin (BIM 23014C) inhibition on vascular smooth muscle cell proliferation in chronic rejection.
Räisänen-Sokolowski A; Mennander A; Ustinov J; Paavonen T; Häyry P
Transplant Proc; 1993 Feb; 25(1 Pt 2):944-5. PubMed ID: 8095115
[No Abstract] [Full Text] [Related]
12. Experimental model of chronic renal allograft rejection in rats and therapeutic efficacy of a new selective thromboxane A2 (TXA2) synthetase inhibitor (CV-4151).
Tanabe K; Toma H; Sagara R; Takahashi K; Teraoka S; Ota K
Transplant Proc; 1989 Feb; 21(1 Pt 1):293-5. PubMed ID: 2650124
[No Abstract] [Full Text] [Related]
13. Chronic rejection of rat aortic allografts: effect of inhibition of the thromboxane cascade.
Mennander A; Ustinov J; Paavonen T; Räisänen A; Häyry P
Transpl Int; 1992; 5 Suppl 1():S587-8. PubMed ID: 14621882
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.
Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
J Clin Invest; 1993 Aug; 92(2):549-58. PubMed ID: 8394384
[TBL] [Abstract][Full Text] [Related]
15. Effect of immunosuppression on chronic rejection in the rat aortic allograft model.
Belitsky P; Gulanikar A; He G; Gupta R
Transplant Proc; 1993 Feb; 25(1 Pt 2):935. PubMed ID: 8442272
[No Abstract] [Full Text] [Related]
16. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis.
Mennander A; Räisänen A; Paavonen T; Häyry P
Transplantation; 1993 Jan; 55(1):124-8. PubMed ID: 8420036
[TBL] [Abstract][Full Text] [Related]
17. Chronic allograft rejection: an update.
Häyry P; Yilmaz S
Transplant Proc; 1994 Dec; 26(6):3159-60. PubMed ID: 7998102
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin analog lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis.
Häyry P; Räisänen A; Ustinov J; Mennander A; Paavonen T
FASEB J; 1993 Aug; 7(11):1055-60. PubMed ID: 8370476
[TBL] [Abstract][Full Text] [Related]
19. Hyperlipidemia enhances chronic rejection in experimental rat model.
Tilly-Kiesi M; Räisänen-Sokolowski A; Ustinov J; Myllärniemi M; Tikkanen MJ; Häyry P
Transplant Proc; 1995 Feb; 27(1):582. PubMed ID: 7879107
[No Abstract] [Full Text] [Related]
20. Pathophysiology of allograft arteriosclerosis.
Häyry P; Paavonen T; Mennander A; Ustinov J; Räisänen A; Lemström K
Transplant Proc; 1993 Apr; 25(2):2070. PubMed ID: 8470274
[No Abstract] [Full Text] [Related]
[Next] [New Search]
